MedPath

DIPHENHYDRAMINE HCI

DIPHENHYDRAMINE HCI INJECTION, USP 50mg/mL 1mL CARP

Approved
Approval ID

7b05c2ef-24eb-f754-e053-2991aa0afbae

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 19, 2020

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DIPHENHYDRAMINE HCI

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1218
Application NumberANDA040140
Product Classification
M
Marketing Category
C73584
G
Generic Name
DIPHENHYDRAMINE HCI
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateFebruary 19, 2020
FDA Product Classification

INGREDIENTS (4)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
DIPHENHYDRAMINE HYDROCHLORIDEActive
Quantity: 50 mg in 1 mL
Code: TC2D6JAD40
Classification: ACTIB
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIPHENHYDRAMINE HCI - FDA Drug Approval Details